UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2015-10, Vol.373 (15), p.1418-1428

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-10, Vol.372 (9648), p.1463-1472

2008

Link zum Volltext

Verfügbarkeit prüfen

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Link zum Volltext

Verfügbarkeit prüfen

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Lancet neurology, 2010-04, Vol.9 (4), p.381-390

2010

Link zum Volltext

Verfügbarkeit prüfen

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Patient preference and adherence, 2017-01, Vol.11, p.33-45

2017

Link zum Volltext

Verfügbarkeit prüfen

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Lancet neurology, 2014-05, Vol.13 (5), p.472-481

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study

Multiple sclerosis, 2012-03, Vol.18 (3), p.314-321

2012

Link zum Volltext

Verfügbarkeit prüfen

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica

PloS one, 2015-05, Vol.10 (5), p.e0125034-e0125034

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials

PloS one, 2012-10, Vol.7 (10), p.e45409-e45409

2012

Link zum Volltext

Verfügbarkeit prüfen

Acquired disorders of the neuromuscular junction

International anesthesiology clinics, 2006-05, Vol.44 (2), p.107-121

O'Neill, Gilmore N

2006

Link zum Volltext

Verfügbarkeit prüfen

Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds

Journal of lipid research, 2000-03, Vol.41 (3), p.433-441

2000

Link zum Volltext

Verfügbarkeit prüfen

Inherited disorders of the neuromuscular junction

International anesthesiology clinics, 2006-05, Vol.44 (2), p.91-106

O'Neill, Gilmore N

2006

Link zum Volltext

Verfügbarkeit prüfen

Case 22-2006: A 77-Year-Old Man with a Rapidly Progressive Gait Disorder

The New England journal of medicine, 2006-07, Vol.355 (3), p.296-304

2006

Link zum Volltext

Verfügbarkeit prüfen

Responsiveness of the Expanded Disability Status Scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis

Revista de neurologiá, 2010-09, Vol.51 (6), p.321-329

2010

Link zum Volltext

Verfügbarkeit prüfen

Sensibilidad de la escala ampliada del estado de discapacidad (EDSS) a la progresión de la enfermedad y la intervención terapéutica en las formas progresivas de la esclerosis múltiple

Revista de neurologiá, 2010-09, Vol.51 (6), p.321

2010

Link zum Volltext

Verfügbarkeit prüfen

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers

Clinical neuropharmacology, 2010-03, Vol.33 (2), p.55-60

2010

Link zum Volltext

Verfügbarkeit prüfen

ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN

Neurology, 2001-12, Vol.57 (11), p.1956

2001

Link zum Volltext

Verfügbarkeit prüfen

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica: e0125034

PloS one, 2015-05, Vol.10 (5)

2015

Link zum Volltext

Verfügbarkeit prüfen

Sixteen novel mutations in the Cu Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes

Amyotrophic lateral sclerosis, 2003-06, Vol.4 (2), p.62-73

2003

Link zum Volltext

Verfügbarkeit prüfen

A Man with a Gait Disorder/THE DISCUSSANT REPLIES

The New England journal of medicine, 2006-10, Vol.355 (16), p.1740

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of BG-I2 on contrast-enhanced lesions in patients with relapsing― remitting multiple sclerosis: subgroup analyses from the phase 2b study

Multiple sclerosis, 2012, Vol.18 (3), p.314-321

2012

Link zum Volltext

Verfügbarkeit prüfen

A Man with a Gait Disorder

The New England journal of medicine, 2006-10, Vol.355 (16), p.1740-1740

2006

Link zum Volltext

Verfügbarkeit prüfen

A man with a rapidly progressive grait disorder

The New England journal of medicine, 2006, Vol.355 (3), p.296-304

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis : a multicentre, randomised, double-blind, placebo-controlled phase lib study. Commentary

The Lancet (British edition), 2008, Vol.372 (9648)

2008

Link zum Volltext

Verfügbarkeit prüfen

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL: Case 22-2006

The New England journal of medicine, 2006-07, Vol.355 (3), p.296

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Humans
(25)
Male
(20)
Female
(13)
Middle Aged
(12)
Adult
(11)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Neurology
(10)
Neurosciences & Neurology
(9)
Treatment Outcome
(9)
Clinical Neurology
(8)
Multiple Sclerosis
(8)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Double-Blind Method
(6)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(6)
Dose-Response Relationship, Drug
(5)
Young Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica

Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials

Acquired disorders of the neuromuscular junction

Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds

Inherited disorders of the neuromuscular junction

Case 22-2006: A 77-Year-Old Man with a Rapidly Progressive Gait Disorder

Responsiveness of the Expanded Disability Status Scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis

Sensibilidad de la escala ampliada del estado de discapacidad (EDSS) a la progresión de la enfermedad y la intervención terapéutica en las formas progresivas de la esclerosis múltiple

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers

ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica: e0125034

Sixteen novel mutations in the Cu Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes

A Man with a Gait Disorder/THE DISCUSSANT REPLIES

Effect of BG-I2 on contrast-enhanced lesions in patients with relapsing― remitting multiple sclerosis: subgroup analyses from the phase 2b study

A Man with a Gait Disorder

A man with a rapidly progressive grait disorder

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis : a multicentre, randomised, double-blind, placebo-controlled phase lib study. Commentary

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL: Case 22-2006

Suchergebnisse filtern